April 9, 2024Oncology LettersOpen Access

Pan‑immune‑inflammation value as a novel prognostic biomarker in nasopharyngeal carcinoma

View Full Paper

Ask AI

Bookmark

Elevated pan-immune-inflammation value predicts worse survival in nasopharyngeal carcinoma, yielding a lower five-year overall survival rate of 68.7% versus 86.9%.
Cox hazards regression models evaluated 319 patients undergoing chemoradiotherapy, establishing an optimal prognostic cut-off value of 428.0 using receiver operating characteristics.
Prospective validation is warranted to confirm how pan-immune-inflammation value outperforms systemic immune-inflammation index for risk stratification during chemoradiotherapy.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Survival analysis reveals worse overall survival with high pan-immune-inflammation values in nasopharyngeal carcinoma, highlighting its utility over other inflammatory indices.

Cite This Study

Su et al. (2024) studied this question.

synapsesocial.com/papers/68e6fca8b6db6435876768f8 https://doi.org/10.3892/ol.2024.14385

View Full Paper

Ask AI

Bookmark

Implication

Survival analysis reveals worse overall survival with high pan-immune-inflammation values in nasopharyngeal carcinoma, highlighting its utility over other inflammatory indices.

Pan‑immune‑inflammation value as a novel prognostic biomarker in nasopharyngeal carcinoma

Key Points

Discussion

Implication

Cite This Study

Pan‑immune‑inflammation value as a novel prognostic biomarker in nasopharyngeal carcinoma

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider